Bruker Announces Novel D8 VENTURE BIOTOOLS™ for Advanced Structural Biology Research by X-Ray Crystallography

HYDERABAD, India, Aug. 21, 2017 /PRNewswire/ — At the 24th Congress & General Assembly of the International Union of Crystallography (IUCr), Bruker today announces the new, high-performance D8 VENTURE BIOTOOLS™ for laboratory macromolecular crystallography. The D8 VENTURE BIOTOOLS feature major advances in source, detector and sample handling technology: The new ImS DIAMOND™ is the world’s brightest microfocus X-ray source.... Read more

Hungarian Ministry of Agriculture Selects Bruker NMR FoodScreener® for Authentication and Identification of Hungarian Wines

BUDAPEST, Hungary, Aug. 8, 2017 /PRNewswire/ — The Hungarian Ministry of Agriculture has selected Bruker’s collaboration partner Diagnosticum to implement a new program to authenticate and identify Hungarian wines. Diagnosticum and Bruker will form the Hungarian Wine Consortium and develop a Hungarian wine model based on Bruker’s NMR FoodScreener technology for rapid and comprehensive wine-profiling.... Read more

Bruker Introduces Software Package for Layer Analysis with XTrace Micro-XRF on Electron Microscopes

ST. LOUIS, Missouri – August 7, 2017 – At the Microscopy & Microanalysis 2017 Meeting Bruker today presents XMethod, the world’s first software package for the analysis of composition and thickness of single or multiple layers, based on data obtained by sample excitation with the XTrace micro-focus X-ray source for scanning electron microscopes (SEM). The software enables... Read more

Bruker Announces Acquisition of Field-Portable Platform for Fast and Universal Immunoassay-Detection of Bacteria, Viruses and Toxins

LEIPZIG, Germany, Aug. 2, 2017 /PRNewswire/ — Bruker today announced the closing of a technology platform and product line acquisition to further expand its range of bacterial, viral and toxin detection solutions for homeland security bio-detection and for selected microbiology applications.  Financial details were not disclosed. The acquired assets include intellectual property, a field-portable, electrochemical chip-based detection... Read more

Bruker Announces Updated D2 PHASERTM Benchtop X-ray Diffraction (XRD) System with LYNXEYE XE-TTM One-dimensional Detector

BIG SKY, Montana (USA) – July 31st, 2017 – At the 66th annual Denver X-ray Conference, Bruker announces the availability of the LYNXEYE XE-T next generation one-dimensional compound silicon strip detector, further enhancing the performance of its popular D2 PHASERTM benchtop X-ray diffraction (XRD) system. The versatile hardware of the updated D2 PHASER combined with the Bruker DIFFRAC.SUITETM software allows users the flexibility to create... Read more

Bruker Announces US FDA Clearance of Expanded 3rd Claim for MALDI Biotyper

BILLERICA, Mass., July 31, 2017 /PRNewswire/ — Bruker today announces that it has received US Food & Drug Administration (FDA) clearance for its third, further expanded claim for the market-leading MALDI Biotyper-CA (MBT-CA) system for fast, accurate and cost-effective microbial identification. The new claim includes a significant expansion of the microbial reference library for clinical... Read more

In Memoriam: The Company was deeply saddened to learn of Mr. Chris van Ingen’s passing on June 27, 2017.

Mr. van Ingen served on the Company’s Board from 2012 to June 2017, and as a director of Bruker Energy & Supercon Technologies, Inc., a wholly-owned subsidiary of the Company, from 2009 to 2013. The Company’s Board and management are extremely grateful for Mr. van Ingen’s guidance and leadership over the years and extend their deepest condolences to his... Read more

Bruker Announces Novel NMR Phenomics Research Capabilities

BRISBANE, Australia, June 26, 2017 /PRNewswire/ — At the Metabolomics Society Meeting 2017, Bruker announces a new solution for the quantification of metabolites in urine using Nuclear Magnetic Resonance (NMR). Urine metabolic analysis is particularly valuable and information-rich, because the metabolic pathways of a wide range of nutrients, drugs and environmental contaminants can be identified in urine,... Read more

Bruker Corporation to Present at Investor Conferences

BILLERICA, Mass., June 2, 2017 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences: Jefferies 2017 Healthcare Conference, New York, NYThursday, June 8, 2017, at 1:30 p.m. Eastern TimeFrank Laukien, President and Chief Executive OfficerJuergen Srega, President, Bruker CALID Group William Blair 37th Annual Growth Stock Conference, Chicago, ILTuesday, June... Read more

Bruker Introduces New Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control at the ASM Microbe 2017 Meeting

NEW ORLEANS, June 1, 2017 /PRNewswire/ — At the American Society for Microbiology (ASM) Microbe 2017 meeting (www.asm.org), Bruker introduces major innovations for strain typing, hospital hygiene and infection control. The novel, bench-top IR Biotyper system for microbial strain typing is based on Fourier-Transform Infrared (FTIR) spectroscopy technology, and complements Bruker’s world-leading MALDI Biotyper mass... Read more